E0784: Insulin pump. What Medicare needs on the order
E0784 is an external ambulatory insulin infusion pump. Medicare covers it for diabetes when a C-peptide or beta cell antibody test qualifies the patient and they either completed a multiple daily injection program with frequent glucose testing or already used a pump before Medicare.
HCPCS E0784
- Official description
- External ambulatory infusion pump, insulin
- Short descriptor
- Ext amb infusn pump insulin
- Medicare policy
- LCD L33794, article A52507
- Payment
- Capped rental: rented for up to 13 months, then the patient owns it
- Prior authorization
- Not required by Medicare
- Face-to-face and order before delivery
- Not on the CMS list. The patient must be seen at least every 3 months for coverage to continue.
- Last checked
- November 11, 2026
What the code covers
E0784 is an external insulin pump that delivers insulin under the skin continuously. Its supplies have their own codes: A4224 covers all infusion supplies for one week, and A4225 is the syringe-type reservoir. Insulin used in the pump is billed as J1811, J1813 or J1817. A pump with built-in continuous glucose sensing is billed as E0784 plus the CGM receiver code (E2103 or E2102), and then the patient must meet the CGM criteria too.
When Medicare covers it
The patient must have diabetes, with a diagnosis listed in the Policy Article, and meet criterion A or B, and criterion C or D.
- A. C-peptide test. A C-peptide level at or below 110% of the lab’s lower limit of normal, or at or below 200% for a patient with renal insufficiency and creatinine clearance of 50 ml/minute or less. A fasting blood sugar taken at the same time must be 225 mg/dl or less.
- B. Beta cell autoantibody test that is positive.
- C. Injection history. The patient completed a comprehensive diabetes education program, has been on at least 3 insulin injections a day with frequent self-adjustment for at least 6 months before starting the pump, and tested glucose an average of at least 4 times a day in the 2 months before starting, and while on injections had at least one of: an HbA1C above 7%, recurring hypoglycemia, wide swings in blood glucose before meals, dawn phenomenon with fasting sugars often above 200 mg/dL, or severe glycemic excursions.
- D. Pump before Medicare. The patient was on an insulin pump before enrolling in Medicare and tested glucose an average of at least 4 times a day in the month before enrolling.
The Policy Article says a patient using a CGM is testing more than 4 times a day, so documented CGM use meets the testing frequency requirement.
Continued coverage. The treating practitioner must see and evaluate the patient at least every 3 months. The pump must be ordered, and follow-up care given, by a practitioner who manages several patients on insulin pumps and works with a team of nurses, diabetes educators and dietitians who know the therapy.
What the order and records need
- A standard written order for the pump and its supplies, with the patient’s name or MBI, the order date, the items, the quantities, and the treating practitioner’s name or NPI and signature.
- The C-peptide and fasting glucose results, or the antibody result.
- The injection history and glucose testing records for criterion C, or the pre-Medicare pump and testing records for criterion D.
- Notes from visits at least every 3 months.
- Proof of delivery, and refill requests for supplies.
Medicare does not require prior authorization for E0784. No certificate of medical necessity is needed either: CMS stopped requiring CMNs for dates of service on or after January 1, 2023.
Modifiers
- RR with KH, KI and KJ for the rental months.
- KX on the pump, insulin and supply lines only when all coverage criteria are met, GA with a valid ABN when they are not, or GZ without one. Lines without one of them are rejected as missing information.
- JK on a one-month or shorter supply of pump insulin, and JL on a three-month supply. Since July 1, 2023, the patient’s coinsurance for a month’s supply of pump insulin is capped at $35.
Rental or purchase
E0784 is a capped rental item on the DMEPOS fee schedule. Medicare pays monthly rentals for up to 13 months of continuous use, and then the patient owns the pump.
Why claims get denied
- No qualifying C-peptide or antibody result, or no record of the injection program and testing frequency. These are medical necessity denials like CO-50, and they take the supplies and insulin down with the pump.
- No visit in the last 3 months.
- A pump other than E0784 billed for insulin, or non-insulin pump supplies (A4221, A4222, K0552) billed with E0784.
- KX, GA or GZ is missing. See CO-4, and MA130 for claims returned as unprocessable.
Sources
Last checked November 11, 2026 against the documents below. These are the Medicare fee-for-service rules that the DME MACs (Noridian and CGS) apply. Medicare Advantage plans, Medicaid and commercial payers set their own rules, so requirements can differ by payer. Policies change, so check the current version before you rely on a detail.
- LCD L33794: External Infusion Pumps
- Policy Article A52507: External Infusion Pumps
- CGS Jurisdiction C: Local Coverage Determinations
- Policy Article A55426: Standard Documentation Requirements for All Claims Submitted to DME MACs
- CMS HCPCS quarterly update (official code descriptors)
- CMS DMEPOS fee schedule (payment category of each code)
- CMS Required Prior Authorization List
- CMS Required Face-to-Face Encounter and Written Order Prior to Delivery List
Run your revenue cycle as workflows.
We are working with a small group of billing and operations teams to shape worklist. Tell us where your work gets stuck, and we'll show you how it would run.